Search Emergency Care Institute
Results
441 - 450 of 1025 results found.
-
Pleural effusion - classification
Working to improve outcomes for patients presenting at hospital emergency departments across NSW through coordination, networking and research.
Page | Clinical resources | Date: 01/09/2016
-
Massive Haemoptysis - investigations
Working to improve outcomes for patients presenting at hospital emergency departments across NSW through coordination, networking and research.
Page | Clinical resources | Date: 01/09/2016
-
Pulmonary Thromboembolism - PE - Risk of Recurrent VTE
HIGH RISK FACTORS FOR RECURRENT VTE. LOW RISK FACTORS FOR RECURRENT VTE. Male gender. Female gender. VTE not provoked by a reversible factor. surgery, pregnancy, fracture. VTE provoked by a reversible factor. surgery, pregnancy, fracture. Cancer.
Page | Clinical resources | Date: 01/09/2016
-
Emergency care assessment and treatment (ECAT): Implementation plan
Emergency care assessment and treatment: Implementation plan February 2024. NSW Agency for Clinical Innovation | aci.health.nsw.gov.au 1. Emergency care assessment and treatment (ECAT) Implementation plan. February 2024. Emergency care assessment
https://aci.health.nsw.gov.au/__data/assets/pdf_file/0006/923235/ECAT-implementation-plan.pdf
-
Emergency Departments are critical in identifying and responding to domestic and family violence. Approximately 38% of women who present to EDs have experienced physical abuse in their lifetime, and of those, approximately 12-14% have experienced
Page | Clinical resources | Date: 28/07/2021
-
Bladder Irrigation - Management of haematuria - Clinical guideline
Street address: Level 4, Sage Building 67 Albert Avenue Chatswood NSW 2067. Postal address: Agency for Clinical Innovation PO Box 699 Chatswood NSW 2057. T 61 2 9464 4666 F 61 2 9464 4728 info@aci.health.nsw.gov.au www.aci.health.nsw.gov.au. ACI
https://aci.health.nsw.gov.au/__data/assets/pdf_file/0019/191062/ACI-Bladder-scanning-adult.pdf
-
Procedural Sedation - Medications
Midazolam. Midazolam acts by potentiating GABA inhibitory action in the CNS by binding to benzodiazepine specific receptors on GABA/Benzodiazepinereceptor complex. This results in sedation, amnesia and anxiolysis. It has no analgesic properties.
Page | Clinical resources | Date: 05/12/2016
-
Ultrasound Logbooks and Assessments
Agency for Clinical Innovation 2024 |.
Page | Clinical resources | Date: 01/09/2016
-
Massive Haemoptysis - common aetiologies
Working to improve outcomes for patients presenting at hospital emergency departments across NSW through coordination, networking and research.
Page | Clinical resources | Date: 01/09/2016
-
Massive Haemoptysis - management aims
Working to improve outcomes for patients presenting at hospital emergency departments across NSW through coordination, networking and research.
Page | Clinical resources | Date: 01/09/2016
Debug info
Current query string:
query=!padrenull&profile=_default&collection=aci-eci&start_rank=441&form=json&meta_t_not=404
Current Matrix GET variables:
{"query":"!padrenull","profile":"_default","collection":"aci-eci","start_rank":"441","form":"json","meta_t_not":"404","resultsTemplateID":"669066"}
Reset search page
Link to REST URL